Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Carlos A. Zarate

Experimental Therapeutics & Pathophysiology Branch

Division of Intramural Research Programs

National Institute of Mental Health

National Institutes of Health

USA

[email]@mail.nih.gov

Name/email consistency: high

[Claim this account]

Affiliations

Experimental Therapeutics & Pathophysiology Branch, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, USA. 2007 - 2010
Laboratory of Molecular Pathophysiology and Experimental Therapeutics, Bethesda, Maryland, USA. 2005 - 2009
Mark O Hatfield CRC, Bethesda, Maryland 20892, USA. 2008
Mood and Anxiety Disorders Program, National Institute of Mental Health, Department of Human Health Services, Bethesda, USA. 2006

References

Glutamatergic modulators: the future of treating mood disorders? Zarate, C., Machado-Vieira, R., Henter, I., Ibrahim, L., Diazgranados, N., Salvadore, G. Harv. Rev. Psychiatry (2010) [Pubmed]
Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. Zarate, C.A., Manji, H.K. CNS. Drugs (2009) [Pubmed]
Riluzole in psychiatry: a systematic review of the literature. Zarate, C.A., Manji, H.K. Expert. Opin. Drug. Metab. Toxicol (2008) [Pubmed]
The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases. Zarate, C.A., Manji, H.K. Exp. Neurol. (2008) [Pubmed]
Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Zarate, C.A., Singh, J.B., Carlson, P.J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D.A., Manji, H.K. Bipolar. Disord (2007) [Pubmed]
A double-blind, placebo-controlled study of memantine in the treatment of major depression. Zarate, C.A., Singh, J.B., Quiroz, J.A., De Jesus, G., Denicoff, K.K., Luckenbaugh, D.A., Manji, H.K., Charney, D.S. Am. J. Psychiatry (2006) [Pubmed]
Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Zarate, C.A., Singh, J., Manji, H.K. Biol. Psychiatry (2006) [Pubmed]
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Zarate, C.A., Singh, J.B., Carlson, P.J., Brutsche, N.E., Ameli, R., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. Arch. Gen. Psychiatry (2006) [Pubmed]
An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Zarate, C.A., Quiroz, J.A., Singh, J.B., Denicoff, K.D., De Jesus, G., Luckenbaugh, D.A., Charney, D.S., Manji, H.K. Biol. Psychiatry (2005) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.